1 Money-Making Stock Investors Are Sleeping On
ResMed might not be a household name for the average investor, but its portfolio of almost 6,000 patents focused on sleep apnea and respiratory care suggest perhaps it should be. The IP forms an economic moat for ResMed in the medical devices industry, which is massive.
One of the key factors attracting investors to ResMed is the booming sleep apnea devices market, » Read more about: 1 Money-Making Stock Investors Are Sleeping On »
Read More
If You Could Only Buy 1 Stock, This Would Be It
Putting all your eggs in one basket is usually a bad idea, unless that basket is heavily diversified. Yet most companies fail the diversification test. Google is still largely a bet on advertising. Uber is mostly a bet on ridesharing and food delivery. And Netflix is a bet on streaming content. If even the titans of technology fail the diversification test,
» Read more about: If You Could Only Buy 1 Stock, This Would Be It »
Read More
Is Upstart a Screaming Buy?
» Read more about: Is Upstart a Screaming Buy? »
Read More
1 Surefire Stock That Could 2x Your Money
Despite the firm’s revenue and profit numbers being in line with Wall Street estimates, the FinTech stock underwent a sharp decline. Pre-market trading saw the business lose 8% of its value overnight,
» Read more about: 1 Surefire Stock That Could 2x Your Money »
Read More
Why This Doctor Invests In Tesla Weekly?
I met a doctor recently who has been buying up as much Tesla as he can get his hands on. Remarkably he told me that he buys shares of Tesla every single week, accumulating as big a position as he possibly can.
In light of Tesla shares falling this past week after Musk made some almost outlandish predictions –
» Read more about: Why This Doctor Invests In Tesla Weekly? »
Read MoreThe Burst
Billionaire Buys Stake In Gene Therapy Stock
Ultragenyx may not have crossed your radar but it’s already in billionaire Stan Druckenmiller’s portfolio. What has he spotted in this novel therapies for rare and ultra-rare genetic diseases firm that convinced him to take a position?
Its focus on underserved patient populations, deep pipeline of innovative products, and strong track record in obtaining regulatory approvals make it an attractive long-term investment,
» Read more about: Billionaire Buys Stake In Gene Therapy Stock »
Read MoreThe Ivy
5 Stocks Buffett Is Buying and 2 He’s Dumping
In Q4 of last year, Warren Buffett made a few significant changes to the Berkshire Hathaway portfolio. The investing legend sat on the sidelines through much of 2024, with most of his activity accounted for by selling stocks into a high-priced market and consolidating his company’s assets in cash.
With Buffett and his investing team seemingly jumping back into action late last year,
» Read more about: 5 Stocks Buffett Is Buying and 2 He’s Dumping »
Read MoreThe Daily
NASDAQ Index, S&P 500 and Dow Jones Forecasts – US Indices Continue to Look Bullish Overall
Dow Jones 30 Technical Analysis
The Nasdaq looks a little lackluster, but the Dow Jones 30 looks like it is still in the middle of trying to form a bullish flag. I’m very interested in this because it could give us a signal that we are about to break the high,